90 related articles for article (PubMed ID: 20096329)
1. Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemia.
Heuser M; Park G; Moon Y; Berg T; Xiang P; Kuchenbauer F; Vollett S; Lai C; Humphries RK
Exp Hematol; 2010 Mar; 38(3):174-9. PubMed ID: 20096329
[TBL] [Abstract][Full Text] [Related]
2. Searching for leukemia stem cells--not yet the end of the road?
Jordan CT
Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3.
Masson K; Rönnstrand L
Cell Signal; 2009 Dec; 21(12):1717-26. PubMed ID: 19540337
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
Somervaille TC; Cleary ML
Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
[TBL] [Abstract][Full Text] [Related]
6. Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation.
Chatterjee S; Basak P; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2009; 4(3):179-89. PubMed ID: 20232602
[TBL] [Abstract][Full Text] [Related]
7. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
9. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
10. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection.
Kimura T; Asada R; Wang J; Kimura T; Morioka M; Matsui K; Kobayashi K; Henmi K; Imai S; Kita M; Tsuji T; Sasaki Y; Ikehara S; Sonoda Y
Stem Cells; 2007 Jun; 25(6):1348-55. PubMed ID: 17303816
[TBL] [Abstract][Full Text] [Related]
11. RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
Usher SG; Radford AD; Villiers EJ; Blackwood L
Exp Hematol; 2009 Jan; 37(1):65-77. PubMed ID: 18977066
[TBL] [Abstract][Full Text] [Related]
12. The presence or absence of IL-3 during long-term culture of Flt3-ITD and c-Kit-D816V expressing Ba/F3 cells influences signaling outcome.
Kazi JU; Sun J; Rönnstrand L
Exp Hematol; 2013 Jul; 41(7):585-7. PubMed ID: 23528808
[No Abstract] [Full Text] [Related]
13. Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages.
Dannaeus K; Nilsson K; Jönsson JI
Exp Hematol; 1998 Apr; 26(4):345-52. PubMed ID: 9546318
[TBL] [Abstract][Full Text] [Related]
14. Mapping of MN1 sequences necessary for myeloid transformation.
Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
[TBL] [Abstract][Full Text] [Related]
15. Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: identifying the most potent combination.
Huang Y; Ratajczak MZ; Reca R; Xu H; Tanner M; Rezzoug F; Hussain LR; Fugier-Vivier I; Bolli R; Ildstad ST
Transplantation; 2008 Apr; 85(8):1175-84. PubMed ID: 18431239
[TBL] [Abstract][Full Text] [Related]
16. AlphaIIb integrin expression during development of the murine hemopoietic system.
Corbel C; Salaün J
Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
[TBL] [Abstract][Full Text] [Related]
17. Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.
Lai CK; Moon Y; Kuchenbauer F; Starzcynowski DT; Argiropoulos B; Yung E; Beer P; Schwarzer A; Sharma A; Park G; Leung M; Lin G; Vollett S; Fung S; Eaves CJ; Karsan A; Weng AP; Humphries RK; Heuser M
PLoS One; 2014; 9(11):e112671. PubMed ID: 25401736
[TBL] [Abstract][Full Text] [Related]
18. A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.
Kiyoi H; Shiotsu Y; Ozeki K; Yamaji S; Kosugi H; Umehara H; Shimizu M; Arai H; Ishii K; Akinaga S; Naoe T
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4575-82. PubMed ID: 17671144
[TBL] [Abstract][Full Text] [Related]
19. [Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro].
Zhao SM; Gu XC; Chang NB; Xu XD; Peng MT
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1701-5. PubMed ID: 16854326
[TBL] [Abstract][Full Text] [Related]
20. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
Robinson LJ; Xue J; Corey SJ
Exp Hematol; 2005 Apr; 33(4):469-79. PubMed ID: 15781338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
